secwatch.observer — SEC 8-K summary
======================================

Issuer:     BioRestorative Therapies, Inc. (BRTX)
CIK:        0001505497
Form:       8-K
Filed at:   2024-02-08T23:59:59+00:00
Accession:  0001021771-24-000033
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BioRestorative raises $8.1M via warrant exercise and new private placement warrants
--------------------------------------------------------------------------------

- Gross proceeds of $8.1M from exercise of existing warrants for 3,351,580 shares at $2.33/share.
- New warrants issued for up to 2,513,685 shares at $2.43/share, 5-year term, in a private placement.
- Proceeds to fund BRTX-100 clinical trials, metabolic ThermoStem R&D, and working capital.
- Roth Capital Partners served as financial advisor; fee approx. $528,000.
- Existing warrant shares already registered; resale registration for new warrants to be filed within 10 days.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1505497/000102177124000033/0001021771-24-000033-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1505497/000102177124000033/brt8k.htm
  HTML page:      https://secwatch.observer/filing/0001021771-24-000033

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer